MDClone researchers identified the full ILD patient cohort and linked it to long-term outcomes from Israel's national population registry using the MDClone ADAMS Platform.

MDClone offers an innovative, self-service data analytics environment powering exploration, discovery, and collaboration throughout healthcare ecosystems, cross-institutionally, and globally. The powerful underlying infrastructure of the MDClone ADAMS Platform allows users to overcome common barriers in healthcare in order to organize, access, and protect the privacy of patient data while accelerating research, improving operations and quality, and driving innovation to deliver better patient outcomes. Unlike traditional analytics platforms, the MDClone ADAMS Platform introduces a fundamentally different approach to healthcare data analysis, exploration, and action that embraces a fast, non-linear, and fluid process for dynamic data exploration. Platform capabilities include synthetic data, continuous data feeds, longitudinal data, unstructured data, flexible infrastructure, and 3rd party tool integration. Founded in Israel in 2016, MDClone serves major health systems, payers, and life science customers in the United States, Canada, and Israel including the VHA Ecosystem (Dept of Veterans Affairs), The National Institutes of Health, Intermountain Healthcare, Regenstrief Institute, The Ottawa Hospital, and Sheba Medical Center, among other notable institutions. For more information, visit mdclone.com.